Therefore, we selected the DMS114 cell line, a small cell carcinoma-derived cell line, known to have an amplification at the genomic locus harbouring FGFR1 gene [38], to perform growth experiments comparing the two Spry4 variants. The gene discussed is SPRY4; the disease is small cell carcinoma.